| Literature DB >> 30036965 |
Omkar Byadgi1, Yao-Chung Chen2, Shun Maekawa3, Pei-Chyi Wang4,5, Shih-Chu Chen6,7,8,9.
Abstract
In order to understand the molecular basis underlying the host immune response of koi carp (Cyprinus carpio), Illumina HiSeqTM 2000 is used to analyze the muscle and spleen transcriptome of koi carp infected with Aeromonas sobria (A. sobria). De novo assembly of paired-end reads yielded 69,480 unigenes, of which the total length, average length, N50, and GC content are 70,120,028 bp, 1037 bp, 1793 bp, and 45.77%, respectively. Annotation is performed by comparison against various databases, yielding 42,229 (non-redundant protein sequence (NR): 60.78%), 59,255 (non-redundant nucleotide (NT): 85.28%), 35,900 (Swiss-Prot: 51.67%), 11,772 (clusters of orthologous groups (COG): 16.94%), 33,057 (Kyoto Encyclopedia of Genes and Genomes (KEGG): 47.58%), 18,764 (Gene Ontology (GO): 27.01%), and 32,085 (Interpro: 46.18%) unigenes. Comparative analysis of the expression profiles between bacterial challenge fish and control fish identifies 7749 differentially expressed genes (DEGs) from the muscle and 7846 DEGs from the spleen. These DEGs are further categorized with KEGG. Enrichment analysis of the DEGs and unigenes reveals major immune-related functions, including up-regulation of genes related with Toll-like receptor signaling, complement and coagulation cascades, and antigen processing and presentation. The results from RNA-Seq data are also validated and confirmed the consistency of the expression levels of seven immune-related genes after 24 h post infection with qPCR. Microsatellites (11,534), including di-to hexa nucleotide repeat motifs, are also identified. Altogether, this work provides valuable insights into the underlying immune mechanisms elicited during bacterial infection in koi carp that may aid in the future development of disease control measures in protection against A. sobria.Entities:
Keywords: Aeromonas sobria; Illumina paired-end sequencing; immune response; koi carp (Cyprinus carpio); transcriptome
Mesh:
Substances:
Year: 2018 PMID: 30036965 PMCID: PMC6073842 DOI: 10.3390/ijms19072107
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Up-regulation and down-regulation of differential expressed genes (DEGs) in muscle and spleen after challenge with Aeromonas sobria (A. sobria) in koi carp.
Figure 2KEGG (Kyoto Encyclopedia of Genes and Genomes) classifications of DEGs (differentially expressed genes) in muscle. (A) Cellular processes; (B) environmental information processing organismal systems; (C) genetic information processing metabolism; (D) human diseases; (E) metabolism and (F) organismal systems.
Figure 3KEGG (Kyoto Encyclopedia of Genes and Genomes) classifications of DEGs (differentially expressed genes) in spleen. (A) Cellular processes; (B) environmental information processing organismal systems; (C) genetic information processing metabolism; (D) human diseases; (E) metabolism and (F) organismal systems.
Figure 4Toll-like receptor signaling mapping in spleen by KEGG. Red boxes indicate significantly differentially up-regulated expression and white boxes indicate unchanged expression in the transcriptomic profile.
Figure 5Complement cascade pathway mapping in spleen by KEGG. Red boxes indicate significantly differentially up-regulated expression, green box indicate down-regulated expression and white boxes indicate unchanged expression in the transcriptomic profile.
Figure 6Toll-like receptor signaling mapping in muscle by KEGG. Red boxes indicate significantly differentially up-regulated expression and white boxes indicate unchanged expression in the transcriptomic profile.
Figure 7Complement cascade pathway mapping in muscle by KEGG. Red boxes indicate significantly differentially up-regulated expression, green box indicate down-regulated expression and white boxes indicate unchanged expression in the transcriptomic profile.
Immune-related DEGs regulated after infection in muscle and spleen of koi carp.
| Gene | log2 Fold Change (Treat_muscle/PBS_muscle) | Up/Down-Regulation (Treat_muscle/PBS_muscle) | Gene | log2 Fold Change (Treat_spleen/PBS_spleen) | Up/Down-Regulation (Treat_spleen/PBS_spleen) |
|---|---|---|---|---|---|
| Innate Immunity | Innate Immunity | ||||
|
| 4.360256 | Up |
| 3.787257 | Up |
|
| 2.619664 | Up |
| 3.701566 | Up |
|
| 1.726865 | Up |
| −3.67177 | Down |
|
| 4.95002 | Up |
| 1.701046 | Up |
|
| 2.392317 | Up |
| 3.308268 | Up |
|
| 2.415037 | Up |
| −1.15676 | Down |
|
| 9.337622 | Up |
| −9.17742 | Down |
|
| 11.21396 | Up |
| 6.588696 | Up |
|
| 2.374396 | Up |
| 2.670009 | Up |
|
| 13.58918 | Up |
| 12.19013 | Up |
|
| 8.438792 | Up |
| −1.38904 | Down |
| Antigen Processing | Antigen Processing | ||||
|
| 2.235073 | Up |
| −4.78398 | Down |
|
| 7.857981 | Up |
| 11.54978 | Up |
|
| 3.933396 | Up |
| 1.144123 | Up |
|
| 7.857981 | Up |
| 11.54978 | Up |
|
| 3.933396 | Up |
| 1.144123 | Up |
|
| 4.422052 | Up |
| 2.483444 | Up |
| Complement Cascade | Complement Cascade | ||||
|
| 6.954196 | Up |
| 6.722808 | Up |
|
| 1.81526 | Up |
| 2.656724 | Up |
| mannan-binding lectin serine protease 1 | 1.599362 | Up | mannan-binding lectin serine protease 1 | 4.143954 | Up |
|
| 4.712957 | Up |
| 1.467602 | Up |
| alpha-2-macroglobulin | 5.612605 | Up | alpha-2-macroglobulin | 11.84314 | Up |
Simple sequence repeat (SSR) marker discovery.
| Parameter | Number |
|---|---|
| Total number of sequences examined: | 47,881 |
| Total size of examined sequences (bp): | 49,734,288 |
| Total number of identified SSRs: | 11,534 |
| Number of SSRs containing sequences: | 8638 |
| Number of sequences containing more than 1 SSR: | 2103 |
| Number of SSRs present in compound formation: | 943 |
Number of Single nucleotide polymorphism detection with the repeat number.
| Repeat Number | Motif Length | Total | % | |||||
|---|---|---|---|---|---|---|---|---|
| Mono- | Di- | Tri- | Quad- | Penta- | Hexa- | |||
| 4 | 0 | 0 | 0 | 0 | 58 | 52 | 110 | 0.9 |
| 5 | 0 | 0 | 1214 | 112 | 5 | 5 | 1336 | 11.58 |
| 6 | 0 | 1358 | 542 | 78 | 5 | 8 | 1991 | 17.26 |
| 7 | 0 | 705 | 324 | 14 | 1 | 2 | 1046 | 9.06 |
| 8 | 0 | 496 | 242 | 13 | 0 | 0 | 751 | 6.51 |
| 9 | 0 | 345 | 31 | 7 | 0 | 1 | 384 | 3.32 |
| 10 | 0 | 292 | 34 | 3 | 0 | 2 | 331 | 2.86 |
| 11 | 0 | 373 | 33 | 1 | 0 | 0 | 407 | 3.52 |
| 12 | 802 | 279 | 27 | 1 | 1 | 0 | 1110 | 9.62 |
| 13 | 575 | 69 | 15 | 2 | 0 | 0 | 661 | 5.73 |
| 14 | 385 | 87 | 6 | 0 | 0 | 0 | 478 | 4.14 |
| 15 | 239 | 104 | 6 | 2 | 0 | 0 | 351 | 3.04 |
| >15 | 1787 | 1117 | 19 | 6 | 0 | 0 | 2929 | 25.39 |
| Total | 3549 | 5121 | 2487 | 237 | 70 | 70 | 11,534 | 100 |
| % | 30.76 | 44.39 | 21.56 | 2.05 | 0.6 | 0.6 | 99.96 | |
Figure 8Statistics of Single nucleotide polymorphism (SNP) type in cDNA library from control and bacterial infection.
Validation of relative expression levels of immune-related genes after A. sorbia infection from RNA-Seq and real-time polymerase chain reaction.
| Gene | Spleen | Muscle | ||
|---|---|---|---|---|
| RNA-Seq | qPCR | RNA-Seq | qPCR | |
|
| 6.722808 | 2.99 ± 1.90 | 6.954196 | 2.68 ± 1.84 |
|
| 6.588696 | * 24.73 ± 5.75 | 11.21396 | 1.23 ± 0.45 |
|
| 12.19013 | * 140.77 ± 77.4 | 13.58918 | 5.79 ± 3.82 |
|
| 3.701566 | 2.92 ± 0.85 | 2.619664 | 0.76 ± 0.24 |
|
| −1.15676 | 1.50 ± 0.58 | 2.415037 | 0.56 ± 0.16 |
|
| 3.787257 | 9.14 ± 4.53 | 4.360256 | 1.08 ± 0.69 |
|
| −9.17742 | 5.33 ± 2.89 | 9.337622 | 0.25 ± 0.03 |
* Key gene molecules showing difference in expression level between RNA-seq and qPCR in spleen.
Primer name and sequence used in the present study.
| Gene | Sequence (5′-3′) | |
|---|---|---|
|
| Forward | 5′-CCGTTGAGATGCACCATGAGT-3′ |
| Reverse | 5′-TTGACAGACACGTTCTTCACGTT-3′ | |
|
| Forward | 5′-GTAACGTGTGCCGGTTTCTT-3′ |
| Reverse | 5′-GCAACACAAAAGGAAGCACA-3′ | |
|
| Forward | 5′-GCTTGTAGCTGCCGTAGGAC-3′ |
| Reverse | 5′-GGTGGCTTGGAATTAGTG-3′ | |
|
| Forward | 5′-ATACACTCCGCTGCTGCTTT-3′ |
| Reverse | 5′-CAAGCTGAAGGTTTCCAAGC-3′ | |
|
| Forward | 5′-GATGCAAATGCCCTCAAATACA-3′ |
| Reverse | 5′-GGCTCTTGACGTTCCTTTTG-3′ | |
|
| Forward | 5′-TGGCTGGAGAGGATCCATAC-3′ |
| Reverse | 5′-AAAGCCCCTCTGTTTTGGTTG-3′ | |
|
| Forward | 5′-CAGTTCTGTGTTGCGACGTT-3′ |
| Reverse | 5′-CGGTAAGAACTTGGCACGAT-3′ | |
|
| Forward | 5′-GGCTGGTCTTAGGCAGACAG-3′ |
| Reverse | 5′-CAGCATAGGACCCGTCACTT-3′ |